Tingting Zhang
State Key Laboratory Of Bioactive Substance And Function Of Natural Medicines, Chinese Academy Of Medical Sciences & Peking Union Medical College
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Novel immune-related prognostic models for patients with hepatocellular carcinoma after curative resection.
Journal: Hepatology international
Published: January 15, 2025
Retrospective analysis of colorectal cancer patients with metachronous initially unresectable liver metastases (and no other) achieving no evidence of disease after first-line comprehensive therapy: a multicenter real-world study.
Journal: Journal of cancer research and clinical oncology
Published: April 04, 2023
Pneumatosis intestinalis post steroid use in a patient with immune-related adverse events: Case report, literature review and FAERS analysis.
Journal: Frontiers in pharmacology
Published: December 29, 2022
Should migraine without aura be further divided? A study of 1444 female patients with migraine without aura.
Journal: The journal of headache and pain
Published: November 25, 2022
SCARB2 drives hepatocellular carcinoma tumor initiating cells via enhanced MYC transcriptional activity.
Journal: Nature communications
Published: October 01, 2022
Metabolic regulation of homologous recombination repair by MRE11 lactylation.
Journal: Cell
Published: August 27, 2022
Structure-Based Virtual Screening towards the Discovery of Novel ULK1 Inhibitors with Anti-HCC Activities.
Journal: Molecules (Basel, Switzerland)
Published: March 26, 2022
TRIB3 promotes pulmonary fibrosis through inhibiting SLUG degradation by physically interacting with MDM2.
Journal: Acta pharmaceutica Sinica. B
Published: January 10, 2022
A novel prognostic score model based on combining systemic and hepatic inflammation markers in the prognosis of HBV-associated hepatocellular carcinoma patients.
Journal: Artificial cells, nanomedicine, and biotechnology
Published: June 07, 2019
Cytoplasmic expression of estrogen receptor β may predict poor outcome of EGFR-TKI therapy in metastatic lung adenocarcinoma.
Journal: Oncology letters
Published: August 13, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026